Several markers such as ELF, NFS, APRI, FIB-4, FibroTest, and PRO-C3 have been reported to be associated with hepatic fibrosis staging and are used for disease stratification (Sanyal et al., 2023). This evidence concerns the gene C3 and Hepatic fibrosis.